CSS LLC/IL - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
CSS LLC/IL ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2017$8,539,000
+506.5%
3,000,000
+200.0%
0.42%
+396.4%
Q1 2017$1,408,000
-38.0%
1,000,000
-67.2%
0.08%
-40.0%
Q1 2016$2,272,0003,050,0000.14%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,000,000$18,404,0002.40%
Castle Creek Arbitrage, LLC 5,512,000$10,097,0001.08%
Orbimed Advisors 30,000,000$54,794,0000.57%
Graham Capital Management, L.P. 7,000,000$12,833,0000.34%
WOLVERINE ASSET MANAGEMENT LLC 10,010,000$18,308,0000.23%
LAZARD ASSET MANAGEMENT LLC 16,000,000$29,320,0000.06%
Jefferies Group LLC 3,889,000$7,100,0000.05%
PALISADE CAPITAL MANAGEMENT, LP 535,000$982,0000.04%
Paloma Partners Management Co 1,500,000$2,744,0000.03%
Citadel Advisors 12,990,000$23,907,0000.02%
View complete list of IMMUNOMEDICS INC shareholders